EGElif Tugce Aydin Goker

Elif Tugce Aydin Goker

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Elif Tugce Aydin Goker has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Heavy menstrual bleeding in adolescents: Evaluation of diagnostic indicators and treatment preferences

    by Elif Tugce Aydin Goker, Melis Pehlivanturk Kizilkan, Fatma Gul Ersan, Sinem Akgul, Tekin Aksu, Selin Aytac, Orhan Derman, Ozlem Teksam

    Objective: Heavy menstrual bleeding (HMB) is a significant health concern that may lead to critical medical care and impaired quality of life. The aim of the present study was to identify the clinical indicators of common causes of HMB in adolescents and evaluate the factors influencing the treatment preferences of clinicians.Methods: Between 2010 and 2022, the electronic medical records of adolescents between the ages of 10–18 with HMB were reviewed, and a final of 205 adolescents was included. Clinical, laboratory, and treatment data were retrospectively analyzed.Results: Hypothalamic–pituitary‐ovarian (HPO) axis immaturity was diagnosed in 63.9%, bleeding disorders (BD) in 13.7%, and polycystic ovary syndrome (PCOS) in 12.2% of the patients. The presence of “heavy bleeding” and the bleeding length at presentation were not different between the groups. Patients with a BD presented with lower hemoglobin (Hb) levels (P = 0.019), and more frequently required inpatient admissions (P = 0.005). Of all patients, 34.6% were given only iron, 44.9% were given a low dose, and 15.6% were given a high‐dose hormone treatment. Factors influencing high‐dose hormone regimens were lower Hb levels (P < 0.001), the place of visit (ER rather than the clinic) (P < 0.001), and the presence of multiple ER visits (P < 0.001).Conclusion: Physicians base their decisions to start high‐dose hormonal therapy on objective parameters such as Hb levels and the need for hospitalization, while more precise guidelines are deemed necessary for initiating low‐dose hormonal therapy. Standardized protocols and their practical implementation at the clinical level are needed for the management of HMB in adolescence.


  • Ganglioneuromas in Childhood: Hacettepe Experience With 70 Cases

    by Elif Tugce Aydin Goker, Bilgehan Yalçın, İbRahim Karnak, Diclehan Orhan, Mithat Haliloglu, Saniye Ekinci, Berna Oguz, Burca Aydin, Nilgun Kurucu, Ali Varan, et al.


  • Clinical features and management of animal bites in an emergency department: a single-center experience

    by Orkun Aydin, Elif Tugce Aydin Goker, Zeynep Aybuke Arslan, Halil Mustafa Sert, Ozlem Teksam

    This study aimed to evaluate the clinical features, management, and outcomes of patients with animal bites presented to the pediatric emergency department of a tertiary center.Patients with ICD-10 ...


  • Open Access

    Multicentric Castleman disease in a DOCK8‐deficient patient with Orf virus infection

    by Elif Tugce Aydin Goker, Deniz Cagdas, Inci Yaman Bajin, Musa Gurel Kukul, Elif Soyak Aytekin, Diclehan Orhan, Alpaslan Alp, Serdar Uzar, Fahriye Sarac, Ates Kara, et al.


  • Open Access

    Multicentric Castleman Disease in a DOCK8 Deficient Patient with Orf Virus Infection

    by Elif Tugce Aydin Goker, Deniz Cagdas Ayvaz, Inci Bajin, Musa Kukul, Elif Soyak Aytekin, Diclehan Orhan, Alpaslan Alp, Serdar Uzar, Fahriye Sarac, Ates Kara, et al.

    Castleman disease is a rare, heterogeneous disorder that driven by proinflammatory responses. Human herpes virus-8 has a major role in pathogenesis of multicentric Castleman disease. There is also a subgroup of cases, human herpes virus-8 negative, idiopathic multicentric Castleman disease. The role of primary immunodeficiencies in idiopathic Castleman disease are poorly described. DOCK8 deficiency is a combined primary immunodeficiency. It has a broad clinic spectrum including atopy, autoimmunity and cancer. We present a 10-year-old, DOCK8 deficient patient. He had giant lobular capillary hemangiomas on his neck, iliac and gluteal regions and multiple lymphadenopathies. Abdominal lymph node pathology revealed hyaline vascular type Castleman disease and human herpes virus-8 staining was negative. His lesions were shown to be infected with orf virus. Our case is the first case to relate idiopathic multicentric Castleman disease and DOCK8 deficiency; also, very unusual presentation of orf virus infection in humans.